GlaxoSmithKline Pharmaceuticals Limited — Others, 28-02-2025: Action(s) initiated or orders passed

GlaxoSmithKline Pharmaceuticals Limited has received a demand order from the Karnataka Commercial Tax Department, totaling ₹8.15 crore, comprised of tax, interest, and penalties related to disputes over GST rates and input tax credit for FY 2020-21. The company reports no immediate impact on its financial operations and is currently evaluating the order for appropriate next steps. Investors may view this as a neutral impact, given the absence of financial disruption, but should remain aware of potential management actions regarding the disputed tax demand.